Latest KFF Health News Stories
Seniors Miss Out On Clinical Trials
Among hurdles: Older adults may have multiple illnesses that could complicate research or they might be unable to manage the commute.
Drop In Sudden Cardiac Arrests Linked To Obamacare
A study published by the Journal of the American Heart Association showed that sudden cardiac arrests dropped by 17 percent in one Oregon county after people gained health insurance through the Affordable Care Act.
Calif. Officials Sound Alarm, Envisioning $114B Hit To Medi-Cal Under U.S. Senate Bill
“Nothing is safe — no population, no services,” the director of the nation’s largest Medicaid program said Wednesday. GOP leaders say they seek to cut costs and widen consumer choices.
Para los adultos jóvenes, el proyecto de salud del Senado tiene buenas y malas noticias
El proyecto de salud del Senado podría ayudar a algunos jóvenes reduciendo el costo de sus primas, pero podría perjudicar a otros que lograron tener cobertura a través de una expansión masiva del Medicaid.
Viewpoints: Drug Testing In Wisconsin; The Ethics Of Discussing Abortion
A selection of opinions on health care from around the country.
Editorial and opinion writers offer their views on health policy buzz words like single-payer, public option and even regulatory relief.
Thoughts On Medicaid: What To Do? Save It? Transform It? Protect Its Beneficiaries?
Opinion writers examine how plans to overhaul Medicaid impact those who rely on it — especially vulnerable populations.
In Defense Of The Senate GOP Plan: A Means To ‘Better Health Care;’ Pathway To Relief
News outlets feature the arguments in favor of the bill from prominent Republican leaders such as Senate Majority Leader Mitch McConnell and Health and Human Services Secretary Tom Price.
Detailing The Harms: The Senate Plan’s Victims; What About Kindness?
Topping opinion writers’ list of harms is the 22 million people who would lose their insurance coverage, but they don’t stop there.
Parsing The Politics: Mitch McConnell’s ‘Misery’; Is It Time ‘Tear Up’ The Bill And ‘Start Over’?
Editorial pages examine the political dynamics at work behind the Senate GOP’s now delayed effort to bring a health bill up for a vote.
Perspectives: A Drug Seen As Epitome Of Personalized Medicine Was Just Approved By FDA
Read recent commentaries about drug-cost issues.
That Scary, Long List Of Side Effects In Drug Ads? It May Not Be Long For This World
News outlets report on stories related to pharmaceutical pricing.
Media outlets report on news from Alabama, Louisiana, Missouri, Texas, California and Kansas.
More Than 100 Patients Ended Lives Under California’s New Aid-In-Dying Law Last Year
The majority, or 58.6 percent, of those who sought the drugs suffered from cancer.
Despite Trump’s Apparent Olive Branch, HIV Advocates Remain Frustrated By Administration
On National HIV Testing Day, the president released a statement urging Americans get tested and fight the virus. But advocates say it’s not enough. In other public health news: Lyme disease, breast-feeding and diabetes treatment.
The Opioid Epidemic Will Get Worse Before It Gets Better, Experts Warn
Stat talks with leading public health experts about the crisis and where it’s headed.
Shares Of Biotech Firm At Center Of Congressional Ethics Uproar Plummet
The controversy over the Australian company Innate Immunotherapeutics entangled now-Health and Human Services Secretary Tom Price and Rep. Chris Collins.
Sen. Warren Says ‘Now It’s Time For The Next Step. And The Next Step Is Single Payer.’
Although the Massachusetts Democrat once dismissed a call from progressives to move the country to a single-payer health system, she endorsed it in a new interview with The Wall Street Journal.
Traditionally Vocal Health Groups’ Silence Over Plan Reflects Newly Splintered Industry
While the bill may represent an existential threat to some insurers, others see it as neutral. However other groups, such as hospitals, nursing homes and veterans’ organizations, are definitely voicing their concerns over the proposed legislation.
Trump Group Pulls No-Holds-Barred Ads Attacking Heller For Opposition To Measure
America First Policies said it decided to take down its ads against Sen. Dean Heller (R-Nev.) because “he has decided to come back to the table to negotiate with his colleagues on the Senate bill.”